Введение
На этой странице представлен всесторонний анализ известной истории инсайдерской торговли David P Schenkein. Инсайдеры — это должностные лица, директора или крупные инвесторы компании. Инсайдерам запрещено совершать сделки в своих компаниях на основе конкретной, закрытой информации. Это не означает, что для них незаконно совершать какие-либо сделки в своих собственных компаниях. Однако они должны сообщать обо всех сделках в SEC по форме 4. Несмотря на эти ограничения, академические исследования показывают, что инсайдеры в целом имеют тенденцию опережать рынок в своих собственных компаниях.
Средняя прибыльность торговли
Средняя прибыльность торговли — это средний доход от всех покупок на открытом рынке, сделанных инсайдером за последние три года. Чтобы рассчитать это, мы проверяем каждую незапланированную покупку инсайдера на открытом рынке, исключая все сделки, которые были отмечены как часть торгового плана 10b5-1. Затем мы рассчитываем среднюю эффективность этих сделок за 3, 6 и 12 месяцев, усредняя каждую из этих продолжительностей, чтобы получить окончательный показатель эффективности для каждой сделки. Наконец, мы усредняем все показатели производительности, чтобы рассчитать показатель производительности для инсайдера. В этот список включены только инсайдеры, совершившие не менее трех сделок за последние два года.
Если прибыльность этой инсайдерской сделки равна «Н/Д», то инсайдер либо не совершал никаких покупок на открытом рынке за последние три года, либо совершенные им сделки слишком недавние, чтобы можно было рассчитать надежные показатели эффективности.
Частота обновлений: ежедневно
Компании с заявленной инсайдерской позицией
В документах SEC указано, что David P Schenkein сообщил о владениях или сделках со следующими компаниями:
Безопасность | Заголовок | Последние зарегистрированные холдинги |
---|---|---|
US:DNLI / Denali Therapeutics Inc. | Director | 15 257 |
US:REGN / Regeneron Pharmaceuticals, Inc. | Director | 448 |
US:AGIO / Agios Pharmaceuticals, Inc. | Director | 126 242 |
US:BLUE / bluebird bio, Inc. | Director | 3 000 |
US:FMI / Foundation Medicine, Inc. | Director | 23 326 |
Как интерпретировать графики
На следующих диаграммах показаны динамика акций ценных бумаг после каждой незапланированной сделки на открытом рынке, совершенной David P Schenkein. Незапланированная сделка — это сделка, которая не была совершена в рамках торгового плана 10b5-1. Динамика акций отображается как совокупное процентное изменение цены акций. Например, если инсайдерская сделка была совершена 1 января 2019 года, на графике будет показано дневное процентное изменение ценной бумаги к текущему дню. Если бы цена акций за это время выросла с 10 до 15 долларов, совокупное процентное изменение цены акций составило бы 50%. Изменение цены с 10 до 20 долларов составит 100%, а изменение цены с 10 до 5 долларов составит -50%.
В конечном счете, мы пытаемся определить, насколько тесно инсайдерские сделки коррелируют с избыточной доходностью (положительной или отрицательной) от цены акций, чтобы увидеть, рассчитывает ли инсайдер свои сделки для получения прибыли от инсайдерской информации. Рассмотрим ситуацию, когда это делал инсайдер. В этой ситуации мы ожидаем либо (а) положительной прибыли после покупок, либо (б) отрицательной прибыли после продажи. В случае (а) график ПОКУПКИ покажет серию восходящих кривых, указывающих на положительную доходность после каждой транзакции покупки. В случае (b) график ПРОДАЖИ будет отображать серию нисходящих кривых, указывающих на отрицательную доходность после каждой транзакции продажи.
Однако одного этого недостаточно, чтобы делать выводы. Если, например, цена акций компании росла нециклически в течение многих лет, то мы ожидаем, что все графики после покупки будут иметь наклон вверх. Аналогичным образом, нециклическое снижение на протяжении многих лет приведет к нисходящему наклону постторговых графиков. Ни один из этих графиков не указывает на инсайдерскую торговую активность.
Самым сильным индикатором была бы ситуация, когда цена акций была чрезвычайно цикличной, и были как положительные сигналы на графике ПОКУПКИ, так и отрицательные участки на графике ПРОДАЖИ. Эта ситуация весьма наводит на мысль о том, что инсайдер рассчитывает сделку в свою финансовую выгоду.
Инсайдерские покупки AGIO / Agios Pharmaceuticals, Inc. – анализ краткосрочной прибыли
В этом разделе мы анализируем прибыльность каждой незапланированной инсайдерской покупки на открытом рынке, совершенной в AGIO / Agios Pharmaceuticals, Inc.. Этот анализ помогает понять, стабильно ли инсайдер генерирует аномальную доходность, и стоит ли за ним следить. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние покупки на открытом рынке, которые не были частью автоматического торгового плана.
Дата сделки | Бегущая строка | Инсайдер | Сообщено Акции |
Сообщено Цена |
Скорректировано Акции |
Скорректировано Цена |
Основа стоимости | Дней до Макс |
Цена в Макс |
Макс Прибыль ($) |
Макс. доход (%) |
---|---|---|---|---|---|---|---|---|---|---|---|
2019-11-13 | AGIO | Schenkein David P | 8 064 | 31,0000 | 8 064 | 31,0000 | 249 984 | 250 | 55.9300 | 201 036 | 80,42 |
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
Инсайдерские продажи AGIO / Agios Pharmaceuticals, Inc. – анализ краткосрочных потерь
В этом разделе мы анализируем возможность избежать краткосрочных потерь при каждой незапланированной инсайдерской продаже на открытом рынке, совершенной в AGIO / Agios Pharmaceuticals, Inc.. Последовательная модель избегания потерь может указывать на то, что будущие сделки купли-продажи могут предсказать снижение цены. Этот анализ проводится в течение одного года после каждой сделки, и результаты являются теоретическими .
В следующей таблице показаны самые последние продажи на открытом рынке, которые не были частью автоматического торгового плана.
Скорректированная цена — это цена, скорректированная на дробление. Скорректированные акции — это акции, скорректированные на дробление.
История инсайдерской торговли
В этой таблице показан полный список инсайдерских сделок, совершенных David P Schenkein, раскрытый Комиссии по ценным бумагам и биржам (SEC).
Дата файла | Тран Дата | Форма | Бегущая строка | Безопасность | Код | Акции | Оставшиеся акции | Процент Изменять |
Делиться Цена |
Тран Ценить |
Оставшийся Ценить |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 6 037 | 15 257 | 65,48 | ||||
2025-01-06 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 166 | 448 | 58,87 | ||||
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -32 312 | 9 220 | -77,80 | 32,87 | -1 062 095 | 303 061 |
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -27 129 | 41 532 | -39,51 | 32,09 | -870 570 | 1 332 762 |
2024-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
M - Exercise | 47 165 | 68 661 | 219,41 | 18,00 | 848 970 | 1 235 898 | |
2024-06-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 3 388 | 126 242 | 2,76 | ||||
2024-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 5 967 | 21 496 | 38,42 | ||||
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -57 471 | 122 854 | -31,87 | 34,89 | -2 005 163 | 4 286 376 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 57 471 | 180 325 | 46,78 | 31,64 | 1 818 382 | 5 705 483 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -11 858 | 122 854 | -8,80 | 33,60 | -398 429 | 4 127 894 | |
2024-02-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 11 858 | 134 712 | 9,65 | 31,64 | 375 187 | 4 262 288 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -20 411 | 122 854 | -14,25 | 33,19 | -677 441 | 4 077 524 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 20 411 | 143 265 | 16,61 | 31,64 | 645 804 | 4 532 905 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | -47 731 | 122 854 | -27,98 | 33,05 | -1 577 510 | 4 060 325 | |
2024-02-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 47 731 | 170 585 | 38,85 | 31,64 | 1 510 209 | 5 397 309 | |
2024-01-04 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 42 | 282 | 17,50 | ||||
2023-09-12 |
|
4 | REGN |
REGENERON PHARMACEUTICALS, INC.
Common Stock |
A - Award | 240 | 240 | |||||
2023-06-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 4 975 | 122 854 | 4,22 | ||||
2023-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 4 216 | 15 529 | 37,27 | ||||
2023-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -16 363 | 117 879 | -12,19 | 22,85 | -373 895 | 2 693 535 |
2023-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 16 363 | 134 242 | 13,88 | 9,05 | 148 085 | 1 214 890 |
2023-03-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -20 000 | 117 879 | -14,51 | 22,15 | -443 000 | 2 611 020 |
2023-03-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -1 667 | 117 879 | -1,39 | 22,72 | -37 874 | 2 678 211 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -18 333 | 119 546 | -13,30 | 22,47 | -411 943 | 2 686 199 |
2023-03-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-03-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -20 000 | 117 879 | -14,51 | 25,37 | -507 400 | 2 990 590 |
2023-03-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-02-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -20 000 | 117 879 | -14,51 | 28,62 | -572 400 | 3 373 697 |
2023-02-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -3 300 | 117 879 | -2,72 | 29,88 | -98 604 | 3 522 225 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -16 700 | 121 179 | -12,11 | 29,22 | -487 974 | 3 540 850 |
2023-02-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -1 034 | 117 879 | -0,87 | 29,49 | -30 493 | 3 476 252 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
S - Sale | X | -18 966 | 118 913 | -13,76 | 28,82 | -546 600 | 3 427 073 |
2023-01-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | X | 20 000 | 137 879 | 16,97 | 9,05 | 181 000 | 1 247 805 |
2022-06-06 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 5 986 | 11 313 | 112,37 | ||||
2022-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock unit |
M - Exercise | -1 585 | 0 | -100,00 | ||||
2022-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 1 585 | 117 879 | 1,36 | ||||
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -2 775 | 0 | -100,00 | ||||
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -758 | 116 294 | -0,65 | 29,08 | -22 043 | 3 381 830 | |
2022-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 775 | 117 052 | 2,43 | ||||
2021-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 6 222 | 6 222 | |||||
2021-06-04 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
A - Award | 2 074 | 5 327 | 63,76 | ||||
2021-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Restricted Stock Units |
M - Exercise | -3 253 | 0 | -100,00 | ||||
2021-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
M - Exercise | 3 253 | 3 253 | |||||
2021-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -1 686 | 0 | -100,00 | ||||
2021-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 1 686 | 114 277 | 1,50 | ||||
2021-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy) |
A - Award | 8 888 | 8 888 | |||||
2021-05-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock unit |
A - Award | 1 585 | 1 585 | |||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -2 774 | 2 775 | -49,99 | ||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -821 | 112 591 | -0,72 | ||||
2021-02-24 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 774 | 113 412 | 2,51 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -8 125 | 0 | -100,00 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -2 540 | 110 638 | -2,24 | ||||
2021-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 8 125 | 113 178 | 7,73 | ||||
2020-12-23 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -5 000 | 26 232 | -16,01 | 90,01 | -450 027 | 2 361 022 |
2020-12-23 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -25 000 | 0 | -100,00 | 90,06 | -2 251 555 | |
2020-11-13 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -30 000 | 25 000 | -54,55 | 70,05 | -2 101 590 | 1 751 325 |
2020-11-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -10 000 | 55 000 | -15,38 | 60,03 | -600 310 | 3 301 705 |
2020-11-06 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
S - Sale | X | -10 000 | 65 000 | -13,33 | 50,18 | -501 830 | 3 261 895 |
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 3 000 | 3 000 | |||||
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 500 | 6 832 | 28,13 | ||||
2020-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 156 | 5 332 | 3,01 | ||||
2020-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Restricted Stock Units |
A - Award | 3 253 | 3 253 | |||||
2020-06-05 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 15 183 | 15 183 | |||||
2020-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
A - Award | 1 686 | 1 686 | |||||
2020-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Stock options (right to buy) |
A - Award | 8 096 | 8 096 | |||||
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -880 | 105 053 | -0,83 | 48,66 | -42 821 | 5 111 879 | |
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -2 775 | 5 549 | -33,34 | ||||
2020-02-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 2 775 | 105 933 | 2,69 | ||||
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
F - Taxes | -2 534 | 103 158 | -2,40 | 52,01 | -131 793 | 5 365 248 | |
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Restricted stock units |
M - Exercise | -8 125 | 8 125 | -50,00 | ||||
2020-02-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
M - Exercise | 8 125 | 105 692 | 8,33 | ||||
2019-11-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS, INC.
Common stock |
P - Purchase | 8 064 | 97 567 | 9,01 | 31,00 | 249 984 | 3 024 577 | |
2019-06-10 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2019-06-10 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 5 176 | 23,95 | ||||
2019-06-03 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 27 245 | 27 245 | |||||
2019-02-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
A - Award | 8 324 | 8 324 | |||||
2019-02-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 45 719 | 45 719 | |||||
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
F - Taxes | -2 471 | 89 503 | -2,69 | 58,03 | -143 392 | 5 193 859 | |
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
M - Exercise | -8 125 | 16 250 | -33,33 | ||||
2019-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 125 | 91 974 | 9,69 | ||||
2018-11-19 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | -1 000 | 270 772 | -0,37 | ||||
2018-09-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -8 730 | 137 471 | -5,97 | ||||
2018-09-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 8 730 | 83 849 | 11,62 | 31,64 | 276 217 | 2 652 982 | |
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -2 500 | 146 201 | -1,68 | ||||
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -72 619 | 0 | -100,00 | ||||
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 2 500 | 75 119 | 3,44 | 31,64 | 79 100 | 2 376 765 | |
2018-09-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 72 619 | 72 619 | 2,34 | 169 928 | 169 928 | ||
2018-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2018-06-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 4 176 | 31,49 | ||||
2018-06-15 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 27 830 | 27 830 | |||||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -108 | 72 619 | -0,15 | |||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -12 892 | 0 | -100,00 | |||
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -100 | 0 | -100,00 | 96,91 | -9 691 | |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 190 | 100 | -96,96 | 96,40 | -307 516 | 9 640 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 200 | 3 290 | -71,37 | 95,11 | -779 902 | 312 912 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 510 | 11 490 | -11,62 | 94,37 | -142 499 | 1 084 311 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 108 | 13 000 | 0,84 | 2,34 | 253 | 30 420 |
2018-06-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 12 892 | 12 892 | 0,47 | 6 027 | 6 027 | |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -23 471 | 12 892 | -64,55 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -16 193 | 0 | -100,00 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -5 962 | 0 | -100,00 | |||
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -45 626 | 0 | -100,00 | 90,07 | -4 109 534 | |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 23 471 | 45 626 | 105,94 | 0,47 | 10 973 | 21 330 |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 16 193 | 22 155 | 271,60 | 0,30 | 4 898 | 6 702 |
2018-06-01 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 5 962 | 5 962 | 0,30 | 1 804 | 1 804 | |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -49 374 | 16 193 | -75,30 | |||
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -299 | 0 | -100,00 | 92,03 | -27 517 | |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -9 301 | 299 | -96,89 | 91,60 | -851 972 | 27 388 |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -39 774 | 9 600 | -80,56 | 90,11 | -3 584 035 | 865 056 |
2018-05-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 49 374 | 49 374 | 0,30 | 14 936 | 14 936 | |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 65 567 | -16,55 | |||
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -100 | 0 | -100,00 | 84,35 | -8 435 | |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 814 | 100 | -96,57 | 83,56 | -235 138 | 8 356 |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 086 | 2 914 | -77,58 | 82,88 | -835 928 | 241 512 |
2018-05-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 78 567 | -14,20 | |||
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 113 | 0 | -100,00 | 79,49 | -167 962 | |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 390 | 2 113 | -61,60 | 78,59 | -266 420 | 166 061 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 340 | 5 503 | -37,77 | 77,76 | -259 718 | 427 913 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 8 843 | -22,72 | 76,40 | -198 640 | 675 605 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 557 | 11 443 | -11,98 | 75,54 | -117 616 | 864 404 |
2018-04-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 91 567 | -12,43 | |||
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 085 | 0 | -100,00 | 81,30 | -819 910 | |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 915 | 10 085 | -22,42 | 80,38 | -234 308 | 810 632 |
2018-03-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Restricted stock units |
A - Award | 24 375 | 24 375 | |||||
2018-02-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 97 500 | 97 500 | |||||
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 000 | 104 567 | -11,06 | |||
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 460 | 0 | -100,00 | 79,23 | -353 366 | |
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 540 | 4 460 | -65,69 | 78,50 | -670 390 | 350 110 |
2018-02-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 000 | 13 000 | 0,30 | 3 932 | 3 932 | |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -23 572 | 117 567 | -16,70 | |||
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 966 | 0 | -100,00 | 82,22 | -243 865 | |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -11 369 | 2 966 | -79,31 | 81,40 | -925 437 | 241 432 |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -9 237 | 14 335 | -39,19 | 80,35 | -742 193 | 1 151 817 |
2018-01-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 23 572 | 23 572 | 0,30 | 7 131 | 7 131 | |
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -20 | 141 139 | -0,01 | |||
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -20 | 0 | -100,00 | 80,01 | -1 600 | |
2018-01-26 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 20 | 20 | 0,30 | 6 | 6 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -13 533 | 141 159 | -8,75 | |||
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -13 533 | 0 | -100,00 | 80,01 | -1 082 775 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 13 533 | 13 533 | 0,30 | 4 094 | 4 094 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -32 875 | 5 962 | -84,65 | |||
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -32 875 | 0 | -100,00 | 80,01 | -2 630 329 | |
2018-01-25 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 32 875 | 32 875 | 0,30 | 9 945 | 9 945 | |
2018-01-25 |
|
4/A | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 38 837 | -13,38 | |||
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -53 000 | 154 692 | -25,52 | |||
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 597 | 0 | -100,00 | 74,80 | -493 456 | |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -10 914 | 6 597 | -62,33 | 74,11 | -808 837 | 488 904 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -22 304 | 17 511 | -56,02 | 73,02 | -1 628 638 | 1 278 653 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -13 185 | 39 815 | -24,88 | 71,77 | -946 287 | 2 857 523 |
2018-01-16 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 53 000 | 53 000 | 0,30 | 16 032 | 16 032 | |
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -19 774 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -19 774 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -105 225 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Series A-1 Preferred Stock |
C - Conversion | -105 225 | 0 | -100,00 | ||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 19 774 | 19 774 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 19 774 | 19 774 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 105 225 | 105 225 | |||||
2017-12-12 |
|
4 | DNLI |
Denali Therapeutics Inc.
Common Stock |
C - Conversion | 105 225 | 105 225 | |||||
2017-12-08 |
|
4 | DNLI |
Denali Therapeutics Inc.
Stock Option (right to buy) |
A - Award | 47 165 | 47 165 | |||||
2017-12-07 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
150 000 | ||||||||
2017-12-07 | 3 | DNLI |
Denali Therapeutics Inc.
Common Stock |
150 000 | ||||||||
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 20 656 | -22,51 | |||
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -400 | 0 | -100,00 | 62,08 | -24 832 | |
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -5 600 | 400 | -93,33 | 61,51 | -344 456 | 24 604 |
2017-12-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 26 656 | -18,37 | |||
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 260 | 0 | -100,00 | 63,32 | -269 743 | |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -942 | 4 260 | -18,11 | 64,64 | -60 891 | 275 366 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -598 | 5 202 | -10,31 | 65,42 | -39 121 | 340 315 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -200 | 5 800 | -3,33 | 66,75 | -13 350 | 387 150 |
2017-11-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -80 000 | 32 656 | -71,01 | |||
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -80 000 | 0 | -100,00 | 70,14 | -5 611 200 | |
2017-10-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 80 000 | 80 000 | 0,30 | 24 200 | 24 200 | |
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 112 656 | -5,06 | |||
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 000 | 0 | -100,00 | 66,76 | -400 560 | |
2017-10-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -35 000 | 118 656 | -22,78 | |||
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -35 000 | 0 | -100,00 | 67,12 | -2 349 200 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 35 000 | 35 000 | 0,30 | 10 588 | 10 588 | |
2017-09-20 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | -500 | 271 772 | -0,18 | ||||
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | -2 000 | 19 361 | -9,36 | ||||
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | -2 000 | 3 176 | -38,64 | 115,07 | -230 145 | 365 470 | |
2017-09-05 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 2 000 | 5 176 | 62,97 | 8,16 | 16 312 | 42 214 | |
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 153 656 | -3,76 | |||
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 000 | 0 | -100,00 | 62,20 | -373 200 | |
2017-09-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -24 000 | 159 656 | -13,07 | |||
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -24 000 | 0 | -100,00 | 60,55 | -1 453 200 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 24 000 | 24 000 | 0,30 | 7 260 | 7 260 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 183 656 | -1,61 | |||
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 55,12 | -165 360 | |
2017-08-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 186 656 | -1,58 | |||
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 51,18 | -153 540 | |
2017-07-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2017-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 3 176 | 45,96 | ||||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -1 900 | 189 656 | -0,99 | |||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 900 | 0 | -100,00 | 50,02 | -95 038 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 900 | 1 900 | 0,30 | 575 | 575 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -1 100 | 191 556 | -0,57 | |||
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 100 | 0 | -100,00 | 50,02 | -55 022 | |
2017-06-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 1 100 | 1 100 | 0,30 | 333 | 333 | |
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 192 656 | -1,53 | |||
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 50,06 | -150 180 | |
2017-05-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 195 656 | -1,51 | |||
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 58,62 | -175 860 | |
2017-04-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
M - Exercise | -5 000 | 21 361 | -18,97 | ||||
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
S - Sale | -5 000 | 2 176 | -69,68 | 89,53 | -447 632 | 194 810 | |
2017-03-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
M - Exercise | 5 000 | 7 176 | 229,78 | 8,16 | 40 779 | 58 526 | |
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -3 000 | 198 656 | -1,49 | |||
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 000 | 0 | -100,00 | 50,47 | -151 410 | |
2017-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 3 000 | 3 000 | 0,30 | 908 | 908 | |
2017-02-23 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 142 900 | 142 900 | |||||
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -6 000 | 201 656 | -2,89 | |||
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 000 | 0 | -100,00 | 50,01 | -300 060 | |
2017-02-17 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 000 | 6 000 | 0,30 | 1 815 | 1 815 | |
2017-01-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 68 182 | 136 363 | 100,00 | ||||
2017-01-23 |
|
4/A | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 2 176 | 85,03 | ||||
2016-06-20 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
A - Award | 12 075 | 23 326 | 107,32 | 19,93 | 240 655 | 464 887 | |
2016-06-03 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 4 000 | 4 000 | |||||
2016-06-03 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
A - Award | 1 000 | 1 000 | |||||
2016-02-18 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 102 000 | 997 501 | 11,39 | ||||
2016-01-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -20 000 | 895 501 | -2,18 | ||||
2016-01-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 20 000 | 272 272 | 7,93 | 0,30 | 6 050 | 82 362 | |
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -10 000 | 915 501 | -1,08 | ||||
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 252 272 | 4,13 | 0,30 | 3 025 | 76 312 | |
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -10 000 | 925 501 | -1,07 | ||||
2016-01-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 242 272 | 4,31 | 0,30 | 3 025 | 73 287 | |
2015-12-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 68 181 | 935 501 | 7,86 | ||||
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -4 000 | 867 320 | -0,46 | |||
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 000 | 232 272 | -1,69 | 80,26 | -321 040 | 18 642 151 |
2015-10-30 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 4 000 | 236 272 | 1,72 | 31,64 | 126 560 | 7 475 646 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -7 299 | 871 320 | -0,83 | |||
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -701 | 878 619 | -0,08 | |||
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 000 | 232 272 | -3,33 | 110,60 | -884 800 | 25 689 283 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 7 299 | 240 272 | 3,13 | 31,64 | 230 940 | 7 602 206 |
2015-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 701 | 232 973 | 0,30 | 0,30 | 212 | 70 474 |
2015-06-22 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
A - Award | 5 997 | 11 251 | 114,14 | 32,23 | 193 283 | 362 620 | |
2015-06-08 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2015-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 232 272 | -2,72 | 120,67 | -784 355 | 28 028 262 |
2015-06-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 232 272 | -2,72 | 120,67 | -784 355 | 28 028 262 |
2015-05-28 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -8 929 | 85 582 | -9,45 | 120,05 | -1 071 926 | 10 274 119 |
2015-05-28 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
G - Gift | -190 | 94 511 | -0,20 | ||||
2015-05-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 093 | 94 701 | -2,16 | 110,03 | -230 293 | 10 419 951 |
2015-05-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 107 | 96 794 | -3,11 | 110,01 | -341 801 | 10 648 308 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 99 901 | -1,28 | 101,32 | -131 716 | 10 121 969 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 238 772 | -1,08 | 101,32 | -263 432 | 24 192 379 |
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -10 000 | 879 320 | -1,12 | ||||
2015-05-11 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 10 000 | 241 372 | 4,32 | 0,30 | 3 025 | 73 015 | |
2015-05-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 900 | 231 372 | -1,66 | 93,63 | -365 157 | 21 663 360 |
2015-04-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 101 201 | -1,27 | 100,03 | -130 039 | 10 123 136 |
2015-04-15 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 235 272 | -1,09 | 100,03 | -260 078 | 23 534 258 |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 996 | 5 254 | -83,19 | 50,00 | -1 299 800 | 262 700 | |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 996 | 5 254 | -83,19 | 50,00 | -1 299 800 | 262 700 | |
2015-04-14 |
|
4/A | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 996 | 5 254 | -83,19 | 50,00 | -1 299 800 | 262 700 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 218 | 6 032 | -80,70 | 50,00 | -1 260 900 | 301 600 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 218 | 6 032 | -80,70 | 50,00 | -1 260 900 | 301 600 | |
2015-04-09 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
U - Other | -25 218 | 6 032 | -80,70 | 50,00 | -1 260 900 | 301 600 | |
2015-04-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 900 | 237 872 | -1,61 | 92,54 | -360 906 | 22 012 675 |
2015-03-09 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 600 | 102 501 | -2,47 | 110,16 | -286 416 | 11 291 510 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 136 000 | 889 320 | 18,05 | ||||
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -1 300 | 105 101 | -1,22 | 107,05 | -139 165 | 11 251 062 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 241 772 | -2,62 | 107,05 | -695 825 | 25 881 693 |
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -25 000 | 753 320 | -3,21 | ||||
2015-03-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | 25 000 | 248 272 | 11,20 | 0,30 | 7 562 | 75 102 | |
2015-02-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -684 | 106 401 | -0,64 | 120,31 | -82 292 | 12 801 104 |
2015-02-13 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -787 | 107 085 | -0,73 | 120,14 | -94 550 | 12 865 192 |
2015-02-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -3 900 | 107 872 | -3,49 | 114,31 | -445 809 | 12 330 848 |
2015-02-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 223 272 | -2,83 | 114,31 | -743 015 | 25 522 222 |
2015-01-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 111 772 | -5,50 | 110,08 | -715 520 | 12 303 862 |
2015-01-06 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 229 772 | -2,75 | 110,08 | -715 520 | 25 293 302 |
2014-12-22 |
|
4 | BLUE |
bluebird bio, Inc.
Common Stock |
P - Purchase | 1 176 | 1 176 | 85,00 | 99 960 | 99 960 | ||
2014-12-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 118 272 | -5,21 | 97,03 | -630 695 | 11 475 932 |
2014-12-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 118 272 | -5,21 | 97,03 | -630 695 | 11 475 932 |
2014-11-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 124 772 | -4,95 | 81,71 | -531 115 | 10 195 120 |
2014-11-04 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 124 772 | -4,95 | 81,71 | -531 115 | 10 195 120 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -2 500 | 778 320 | -0,32 | |||
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 131 272 | -4,72 | 60,07 | -390 455 | 7 885 509 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 131 272 | -4,72 | 60,07 | -390 455 | 7 885 509 |
2014-10-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 2 500 | 255 772 | 0,99 | 0,30 | 756 | 77 371 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | X | -30 000 | 780 820 | -3,70 | |||
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -30 000 | 137 772 | -17,88 | 62,68 | -1 880 400 | 8 635 549 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -30 000 | 137 772 | -17,88 | 62,68 | -1 880 400 | 8 635 549 |
2014-09-29 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 30 000 | 283 272 | 11,84 | 0,30 | 9 075 | 85 690 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
M - Exercise | -6 500 | 810 820 | -0,80 | ||||
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 167 772 | -3,73 | 46,30 | -300 950 | 7 767 844 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -6 500 | 167 772 | -3,73 | 46,30 | -300 950 | 7 767 844 |
2014-09-03 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
M - Exercise | X | 6 500 | 259 772 | 2,57 | 0,30 | 1 966 | 78 581 |
2014-08-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 265 | 174 272 | -1,28 | 40,17 | -90 985 | 7 000 506 |
2014-08-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -2 265 | 253 272 | -0,89 | 40,17 | -90 985 | 10 173 936 |
2014-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 235 | 176 537 | -2,34 | 39,17 | -165 885 | 6 914 954 |
2014-08-05 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common stock |
S - Sale | X | -4 235 | 255 537 | -1,63 | 39,17 | -165 885 | 10 009 384 |
2014-07-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 500 | 180 772 | -3,47 | 46,52 | -302 380 | 8 409 513 |
2014-07-02 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
S - Sale | X | -6 500 | 259 772 | -2,44 | 46,52 | -302 380 | 12 084 593 |
2014-06-20 |
|
4 | FMI |
Foundation Medicine, Inc.
Stock Option (right to buy) |
A - Award | 13 385 | 13 385 | |||||
2014-06-12 |
|
4 | BLUE |
bluebird bio, Inc.
Stock Option (right to buy) |
A - Award | 7 500 | 7 500 | |||||
2014-04-08 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock option (right to buy) |
A - Award | 54 546 | 817 320 | 7,15 | ||||
2014-03-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -25 000 | 762 774 | -3,17 | ||||
2014-03-27 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 25 000 | 266 272 | 10,36 | 0,30 | 7 562 | 80 547 | |
2014-03-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | -54 000 | 787 774 | -6,42 | ||||
2014-03-12 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
M - Exercise | 54 000 | 241 272 | 28,84 | 0,30 | 16 335 | 72 985 | |
2014-03-07 |
|
4 | AGIO |
AGIOS PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 160 000 | 841 774 | 23,47 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -125 000 | 0 | -100,00 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Series A Convertible Preferred Stock |
C - Conversion | -125 000 | 0 | -100,00 | ||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
C - Conversion | 31 250 | 31 250 | |||||
2013-10-02 |
|
4 | FMI |
Foundation Medicine, Inc.
Common Stock |
C - Conversion | 31 250 | 31 250 | |||||
2013-09-24 | 3 | FMI |
Foundation Medicine, Inc.
Common Stock |
31 250 | ||||||||
2013-07-23 | 3 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
187 272 | ||||||||
2013-07-23 | 3 | AGIO |
AGIOS PHARMACEUTICALS INC
Common Stock |
187 272 |